Does CRISABOROLE Cause Drug ineffective for unapproved indication? 230 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 230 reports of Drug ineffective for unapproved indication have been filed in association with CRISABOROLE (Eucrisa). This represents 3.0% of all adverse event reports for CRISABOROLE.
230
Reports of Drug ineffective for unapproved indication with CRISABOROLE
3.0%
of all CRISABOROLE reports
1
Deaths
5
Hospitalizations
How Dangerous Is Drug ineffective for unapproved indication From CRISABOROLE?
Of the 230 reports, 1 (0.4%) resulted in death, 5 (2.2%) required hospitalization.
Is Drug ineffective for unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRISABOROLE. However, 230 reports have been filed with the FAERS database.
What Other Side Effects Does CRISABOROLE Cause?
Drug ineffective (1,815)
Application site pain (1,414)
Burning sensation (975)
Off label use (673)
Condition aggravated (613)
Pain (468)
Pruritus (378)
Rash (342)
Eczema (308)
Erythema (285)
What Other Drugs Cause Drug ineffective for unapproved indication?
GABAPENTIN (5,231)
METHOTREXATE (2,513)
DICLOFENAC (2,154)
RITUXIMAB (1,776)
LIDOCAINE (1,761)
METHYLPREDNISOLONE (1,750)
PREDNISONE (1,598)
MYCOPHENOLATE MOFETIL (1,596)
HUMAN IMMUNOGLOBULIN G (1,527)
DEXAMETHASONE (1,302)
Which CRISABOROLE Alternatives Have Lower Drug ineffective for unapproved indication Risk?
CRISABOROLE vs CRIZANLIZUMAB
CRISABOROLE vs CRIZANLIZUMAB-TMCA
CRISABOROLE vs CRIZOTINIB
CRISABOROLE vs CROFELEMER
CRISABOROLE vs CROMOLYN